Cargando…
Procedural pain and patient-reported side effects with weekly injections of subcutaneous Methotrexate in children with rheumatic disorders
BACKGROUND: Despite the widespread use of subcutaneous methotrexate in treating pediatric rheumatic disorders, the amount of pain associated with the injections has not been quantified. Our study aims 1) to quantify the amount of pain associated with subcutaneous injections of methotrexate, 2) to ex...
Autores principales: | Bechard, Melanie Anne, Lemieux, Julie Rachelle, Roth, Johannes, Watanabe Duffy, Karen, Duffy, Ciaran Maire, Aglipay, Mary Ombac, Jurencak, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290103/ https://www.ncbi.nlm.nih.gov/pubmed/25584042 http://dx.doi.org/10.1186/1546-0096-12-54 |
Ejemplares similares
-
Methotrexate in Rheumatic Disease
por: Hughes, Graham R V
Publicado: (1994) -
The Subcutaneous Nodule of Rheumatism
por: Gollerkeri, P. G.
Publicado: (1938) -
Adverse events during short- and long-term exposure to low-dose weekly methotrexate for rheumatic diseases
por: Garton, Mark, et al.
Publicado: (2023) -
Galactorrhea associated with juvenile systemic lupus erythematosus: a review of the role of prolactin
por: Ronis, Tova, et al.
Publicado: (2009) -
Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis
por: Vena, Gino Antonio, et al.
Publicado: (2018)